Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software | Varian

{ "pageType": "news-article", "title": "Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software", "articleDate": "May 26, 2015", "introText": "", "category": "Oncology" }

Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software

PALO ALTO, Calif. and NEW YORK, May 26, 2015 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR) and Flatiron Health today announced a strategic alliance to develop the next generation of cloud-based, electronic health record (EHR), data analytics and decision support software for cancer care providers around the world. Together, the companies will build upon their existing respective software platforms to deliver a cloud-based integrated medical oncology, radiation oncology and data analytics product suite.

This alliance will enable the two companies to empower both community practices and comprehensive cancer centers with advanced software solutions designed to enhance patient outcomes and streamline operational efficiency. The goal is to offer a suite of cloud-based software solutions that support oncologists in delivering high quality care across the cancer care continuum from screening to survivorship.

"As the oncology industry continues to evolve, we are in need of innovative companies willing to collaborate and think outside the box to build real solutions that transform patient care," said Scot Stevens, chief information officer for UPMC CancerCancer in Pittsburgh, Pennsylvania, which partners with Varian to bring UPMC's clinical and technological expertise to customers. "I am excited to see this alignment of radiation and medical oncology technology in support of cancer care providers worldwide."

As a first step in the collaboration, both companies will offer customers OncoEMR®, Flatiron Health's industry-leading, cloud-based medical oncology EHR. OncoEMR features integrated pathways from multiple organizations such as Via Oncology, as well as a library of managed clinical content including the NCCN Chemotherapy Order Templates (NCCN Templates®). Later this year, OncoEMR will be made seamlessly interoperable with Varian's award-winning ARIA® oncology information system, now in use at over 3,800 cancer centers around the world.

"We are excited to work with an innovative company like Flatiron Health, a leader in the area of workflow management and data analytics for oncology," said Sukhveer Singh, vice president, Oncology Continuum Solutions, Varian Medical Systems. "Together, we will help empower the oncology community to advance the delivery of cancer care. This initiative is an important part of Varian's efforts to build a comprehensive, cloud-based software platform that enables care coordination and value-based medicine."

"We are thrilled to collaborate with Varian, the world's leading supplier of radiation oncology systems for cancer treatment," said Nat Turner, co-founder and CEO, Flatiron Health. "Today's healthcare system requires that cancer care be delivered in a coordinated manner, across multiple specialties. By building and powering software systems that are integrated across medical and radiation oncology, we can help cancer care providers transform the delivery of high quality patient care."

More details about the next generation of oncology technology will be available this Fall. For more information, please visit

About Flatiron Health, Inc.
Flatiron Health helps the oncology community deliver better, more efficient care by powering an innovative cloud-based platform to address today's healthcare challenges. The Flatiron Health OncologyCloud™ platform includes the industry-leading electronic medical record for oncology, advanced analytics, patient portal, and integrated billing management. Backed by Google Ventures, First Round Capital, LabCorp and others, Flatiron's industry-first technology platform and integrated suite of products deliver comprehensive support for cancer care providers and life science companies. For more information, please visit

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging.  The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiation. The company provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of X-ray imaging components, including tubes, digital detectors, and image processing software and workstations for use in medical, scientific, and industrial settings, as well as for security and non-destructive testing.  Varian Medical Systems employs approximately 6,800 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world.  For more information, visit or follow us on Twitter.  For more information, visit or follow us on Twitter.

Forward-Looking Statements
Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this press release regarding industry outlook; the ability of technology and products to treat cancer or increase the quality of cancer care; the ability of products to integrate and become interoperable; future business, events, plans, objectives, functionality, investments, expectations, estimates, and other similar matters; and any statements using the terms "will," "goal," "initiative," "can" or similar statements are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those anticipated.  Such risks and uncertainties include the effect of global economic conditions; demand for the company's products; the company's ability to develop, commercialize, and deploy new products; the company's ability to meet legal and regulatory requirements; changes in the legal or regulatory environment; and the other risks listed from time to time in Varian Medical Systems' filings with the U.S. Securities and Exchange Commission, which by this reference are incorporated herein. These forward-looking statements represent the companies' judgment as of the date of this press release and neither company assumes any obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.




Meryl Ginsberg, 650-424-6444

Adrienne Chen, 929.229.5834



SOURCE Varian Medical Systems